Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.

Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. J Control Release. 2011 Feb 10; 149(3):314-22.

View in: PubMed

subject areas

Antineoplastic Agents
Antitussive Agents
Cell Line
Cell Line, Tumor
Cell Survival
Drug Delivery Systems
Gene Expression Regulation, Neoplastic
Humans
Magnetic Resonance Imaging
Male
Nanoparticles
Noscapine
Prostate
Prostatic Neoplasms
Receptors, Urokinase Plasminogen Activator

authors with profiles

Clayton Yates

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support